Evidence map›Paper›PMID 29532342›Full record

ArticleAnnals of surgical oncology2018

Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study.

Sjors Klompmaker, Jony van Hilst, Sarah L Gerritsen, Mustapha Adham, M Teresa Albiol Quer, Claudio Bassi, Frederik Berrevoet, Ugo Boggi, Olivier R Busch, Manuela Cesaretti and 28 more

Erratum issuedOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Annals of surgical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Distal and Total Pancreatectomy With En Bloc Celiac Axis Resection for Pancreatic Cancer at a High-Volume Center.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors at 13 institutions in 12 countries.

Sjors KlompmakerDepartment of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-1161-7845
Jony van HilstDepartment of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
Sarah L GerritsenDepartment of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
Mustapha AdhamDepartment of Digestive Surgery, E. Herriot Hospital, HCL, UCBL1, Lyon, France.
M Teresa Albiol QuerDepartment of Surgery, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.
Claudio BassiDepartment of Surgery, University of Verona, Verona, Italy.
Frederik BerrevoetDepartment of General and HPB Surgery, Ghent University Hospital, Ghent, Belgium.
Ugo BoggiDivision of General and Transplant Surgery, University of Pisa, Pisa, Italy.
Olivier R BuschDepartment of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
Manuela CesarettiDepartment of HPB Surgery, Hôpital Beaujon, Clichy Cedex, France.
Raffaele Dalla ValleHepato-Pancreato-Biliary Unit, Parma University Hospital, Parma, Italy.
Benjamin DarnisDepartment of Surgery and Liver Transplantation, Croix-Rousse University Hospital, Hospices Civils de Lyon, University of Lyon I, Lyon, France.
Matteo De PastenaDepartment of Surgery, University of Verona, Verona, Italy.
Marco Del ChiaroDepartment of Clinical Science, Intervention and Technology, Karolinska University Hospital, Stockholm, Sweden.
Robert GrützmannDepartment of Surgery, University Hospital Erlangen, Erlangen, Germany.
Markus K DienerDepartment of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany.
Traian DumitrascuCenter of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania.
Helmut FriessDepartment of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
Arpad IvaneczDepartment of Abdominal and General Surgery, University Medical Centre Maribor, Maribor, Slovenia.
Anastasios KarayiannakisSecond Department of Surgery, Democritus University of Thrace, Alexandroupolis, Greece.
Giuseppe K FusaiHPB Surgery and Liver Transplantation Unit, Royal Free Hospital, London, UK.
Knut J LaboriDepartment of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway.
Carlo LombardoDivision of General and Transplant Surgery, University of Pisa, Pisa, Italy.
Santiago López-BenDepartment of Surgery, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.
Jean-Yves MabrutDepartment of Surgery and Liver Transplantation, Croix-Rousse University Hospital, Hospices Civils de Lyon, University of Lyon I, Lyon, France.
Willem NiesenDepartment of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany.
Fernando PardoDepartment of HPB and Transplant Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
Julie PerinelDepartment of Digestive Surgery, E. Herriot Hospital, HCL, UCBL1, Lyon, France.
Irinel PopescuCenter of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania.
Geert RoeyenDepartment of Hepatobiliary, Endocrine and Transplantation Surgery, Antwerp University Hospital, Antwerp, Belgium.
Alain SauvanetDepartment of HPB Surgery, Hôpital Beaujon, Clichy Cedex, France.
Raj PrasadDepartment of HPB and Transplant Services, National Health Service, Leeds, UK.
Christian SturessonDepartment of Surgery, Skåne University Hospital, Lund, Sweden.
Mickael LesurtelDepartment of Surgery and Liver Transplantation, Croix-Rousse University Hospital, Hospices Civils de Lyon, University of Lyon I, Lyon, France.
Jorg KleeffDepartment of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Roberto SalviaDepartment of Surgery, University of Verona, Verona, Italy.
Marc G BesselinkDepartment of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands. m.g.besselink@amc.nl.
E-AHPBA DP-CAR study group
Université Claude Bernard Lyon 1 · FRUniversity of Verona · ITAmsterdam UMC Location University of Amsterdam · NLUniversity of Pisa · ITHeidelberg University · DEDemocritus University of Thrace · GRHôpital Beaujon · FRNational Health Service · GBTUM Klinikum · DEAntwerp University Hospital · BEKarolinska University Hospital · SEOslo University Hospital · NOUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWestern multicenter studies on distal pancreatectomy with celiac axis resection (DP-CAR), also known as the Appleby procedure, for locally advanced pancreatic cancer are lacking. We aimed to study overall survival, morbidity, mortality and the impact of preoperative hepatic artery embolization (PHAE).

methodsRetrospective cohort study within the European-African Hepato-Pancreato-Biliary-Association, on DP-CAR between 1-1-2000 and 6-1-2016. Primary endpoint was overall survival. Secondary endpoints were radicality (R0-resection), 90-day mortality, major morbidity, and pancreatic fistulae (grade B/C).

resultsWe included 68 patients from 20 hospitals in 12 countries. Postoperatively, 53% of patients had R0-resection, 25% major morbidity, 21% an ISGPS grade B/C pancreatic fistula, and 16% mortality. In total, 82% received (neo-)adjuvant chemotherapy and median overall survival in 62 patients with pancreatic ductal adenocarcinoma patients was 18 months (CI 10-37). We observed no impact of PHAE on ischemic complications.

conclusionsDP-CAR combined with chemotherapy for locally advanced pancreatic cancer is associated with acceptable overall survival. The 90-day mortality is too high and should be reduced. Future studies should investigate to what extent increasing surgical volume or better patient selection can improve outcomes.

Indexed as

Embolization, TherapeuticAgedAntineoplastic AgentsCarcinoma, Pancreatic DuctalCeliac ArteryChemoradiotherapy, AdjuvantChemotherapy, AdjuvantEuropeFemaleHepatic ArteryHospitals, High-VolumeHumansMaleMiddle AgedNeoadjuvant TherapyPancreatectomyAntineoplastic Agents

Identifiers

PMID29532342
PMCPMC5891548
OpenAlexW2793063391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.